Chair – Daisy Sahoo, Ph.D.
Associate Professor of Medicine, Cardiovascular Research Center, Medical College of Wisconsin (MCW)
Prof. Sahoo - Faculty Page
Daisy received her B.Sc.(Hon) in Biochemistry from the University of Ottawa (Canada) and her PhD in Biochemistry from the University of Alberta (Canada). Her research focuses on SR-BI-mediated delivery of HDL-cholesterol, reverse cholesterol transport and scavenger receptor biology in atherosclerosis. She plays an active role in graduate and medical student education. She is the Chair of MCW’s Research Affairs Committee. Having served as Chair of MCW’s Women’s Faculty Council, Daisy works closely with MCW Leadership to help develop programs that promote career advancement, faculty retention and promotion, as well as leadership opportunities for women faculty. Daisy is also a member of the ATVB Communications/Membership Committee and previously served on the ATVB Early Career Committee.
Vice Chair – Vasanthy ‘Vas’ Narayanaswami, Ph.D.
Associate Professor, Department of Chemistry & Biochemistry, California State University Long Beach
Long Beach, Calif.
Prof. Narayanaswami - Faculty Page
Vas obtained her B.Sc. in Chemistry from University of Madras and Ph.D. in Chemistry (Biochemistry) at the Indian Institute of Technology, Madras, Chennai, India. She did her post doctoral work as an Alexander von Humboldt fellow at the University of Dusseldorf in Germany, and at the University of Alberta in Edmonton, Canada. She holds an adjunct position at the Children’s Hospital Oakland Research Institute, Oakland, CA. Vas’ research interest is focused on the structural and functional analysis of apolipoprotein E, and its role in oxidative stress, cholesterol transport and cardiovascular/cerebrovascular disease. She is actively involved in increasing diversity in biomedical research and minority access to research careers. Vas is a member of the ATVB Women’s Leadership Committee since June 2013 and currently serves as the Co-Chair.
Immediate Past Chair – Nancy R. Webb, Ph.D.
Professor of Internal Medicine, Cardiovascular Research Center, University of Kentucky
Prof. Webb - Faculty Page
Nancy received her B.A. in Biology at the University of Virginia and her Ph.D. in Microbiology and Immunology at the University of Kentucky. Her research focuses on inflammation, lipoprotein metabolism, and atherosclerosis. Nancy is an active member of the University of Kentucky Graduate Center for Nutritional sciences, serving as a mentor for trainees and new investigators. In addition to chairing the Women’s Leadership Committee, Nancy is also a member of the ATVB Leadership Committee and Nominating Committee. She currently chairs the Research Committee for the AHA Great Rivers Affiliate and serves on the GRA Executive Board.
| ||Hanrui Zhang Ph.D.|
Postdoctoral Fellow, Cardiovascular Institute, University of Pennsylvania
Hanrui received her PhD in Pharmacology at the University of Missouri. Her research focuses on stem cell biology, human functional genomics, cardiovascular physiology, adipose biology, and the mechanisms of cardiometabolic diseases. Hanrui is a member of the ATVB Early Career Committee and the liaison to the Women’s Leadership Committee.
Elena V. Galkina, Ph.D.
Associate Professor of the Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School
Elena received her BS/MS in Biology and Chemistry at the Technological State Institute, Saint-Petersburg, and her Ph.D. in Immunology at the Institute for Experimental Medicine, Saint-Petersburg, Russia. The focus of Dr.Galkina’s laboratory is on the implication of the immune response in atherosclerosis. Dr.Galkina serves as a permanent member of Vascular and Cell Biology Study Section, NIH.
Connie B. Newman, M.D.
Adjunct Associate Professor of Department of Medicine (Endocrinology), New York University School of Medicine
New York, N.Y.
Prof. Newman - Faculty Page
Connie B. Newman, a graduate of Wellesley College ’74 and Weill Cornell Medical College ’78, is a board-certified endocrinologist, and Adjunct Associate Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, NYU School of Medicine, New York, NY. Her expertise is in large cardiovascular clinical outcome trials, drug safety, and management of dyslipidemia and diabetes. She is currently collaborating with investigators at the University of Oxford on a clinical trial evaluating the efficacy and safety of high dose vitamin D. Dr. Newman is Chair of the Special Programs Committee of the Endocrine Society. She is also a member of the Cholesterol Treatment Trialists Collaboration. From 1984 to 1998, Dr. Newman was a member of the faculty of NYU School of Medicine where she conducted basic research on the mammary gland and clinical research on pituitary disease. She was awarded tenure in 1994. In 1998, she joined Merck (1998-2001) and then Pfizer (2001-2007) where she worked predominantly on statins and was responsible for cardiovascular outcome trials, drug safety, and interactions with regulatory agencies. She was Executive Director and leader of the Cardiovascular Regulatory Group at Pfizer.
Dr. Newman is committed to advancing the careers of women in science and medicine. In 2011 she founded the Wellesley College Women in Medicine group which now has about 500 members and connects undergraduate students with physicians and physician-scientists. Dr. Newman is married and has three adult children.
|Isabella Grumbach, M.D.|
Associate Professor of Internal Medicine - Cardiovascular Medicine; University of Iowa Carver College
Dr. Isabella Grumbach MD is a female Internist, has 18 years of experience and practices in Internal Medicine, Cardiovascular Disease, Cardiology, and Interventional Cardiology.
|Alisa Wolberg, M.D.|
Associate Professor; Department of Pathology and Laboratory Medicine (UNC McAllister Heart Institute)
The focus of my research lab is on biochemical, biophysical, and cellular mechanisms governing hemostasis and thrombosis, and analysis of approved and/or novel therapeutics.
Prof. Wolberg - Faculty Page
|Elena Aikawa, PH.D., M.D.|
Prof. Aikawa - Faculty Page
Dr. Elena Aikawa earned her medical degree at the First Moscow Institute of Medicine and obtained her PhD in Pathological Anatomy from the Institute of Biophysics, Moscow. She joined the Department of Pathology at Brigham and Women’s Hospital and Harvard Medical School in 1991 where she conducted studies on the pathogenesis of valvular heart disease. She established a system to identify interstitial valvular cell phenotypes, which currently serves as a useful tool for clinical and basic research applications including cardiac valve tissue engineering. She currently focuses on the application of innovative molecular imaging techniques to explore the new paradigm of cardiovascular calcification as an inflammatory disease. Her recent imaging studies have provided insights into the biology of inflammation-triggered calcification, and aided the investigation of novel, more refined therapeutic strategies to combat calcific cardiovascular disease.
Dr. Aikawa directs the Vascular Biology Program at the Center for Interdisciplinary Sciences at Brigham and Women’s Hospital. She is a member of the NHLBI Working Group on Calcific Aortic Valve Stenosis, which was formed to advise NHLBI on the-state-of-the-art science and on new research directions to improve the understanding and, ultimately, the treatment of calcific aortic valve disease. She is a member of the Editorial Board of Arteriosclerosis Thrombosis and Vascular Biology and PloS ONE, and an active reviewer of major AHA journals, including Circulation, Circulation Research, and Arteriosclerosis Thrombosis and Vascular Biology.
Dr. Aikawa has delivered over 50 invited lectures, and authored over 100 articles on cardiovascular pathobiology. Two of her recent articles that have been published in Circulation were accompanied by an Editorial, and her manuscript on valve molecular imaging received the Best Science Paper Award from Circulation. Most recently, her group has established that arterial and aortic valve calcification inversely correlates with osteoporotic bone remodeling, whereas inflammation and early ectopic calcification are associated with each other, thus suggesting that an understanding of the inflammatory signaling mechanisms may lead to new insights into the selective abrogation of divergent calcific phenomena.